56P Continuation treatment with immunotherapy beyond two years in patients with metastasic non-small cell lung cancer: Retrospective analysis of optimal duration treatment
Titel:
56P Continuation treatment with immunotherapy beyond two years in patients with metastasic non-small cell lung cancer: Retrospective analysis of optimal duration treatment
Auteur:
Pellicer Boigues, A.V. Garde Noguera, J. Garcia Sanchez, J. Piera, N. Fenollosa Sanz, T. Llor Rodriguez, P. Iranzo Barreira, J. Riquelme Cabrera, P. Fernandez Murga Chavanne, M.L. Llombart Cussac, A.